Skip to main content
ECRAID-Base REMAP-CAP

Clinical research response in The Lancet

Published in The Lancet Infectious Diseases, The European clinical research response to optimise treatment of patients with COVID-19: lessons learned, future perspective, and recommendations, this article by Herman Goossens, Lennie Derde, Peter Horby and Marc Bonten discusses how the clinical research community responded to the pandemic in Europe. It focuses on two platform trials: RECOVERY and REMAP-CAP, both of which were able to enrol patients rapidly at the beginning of the pandemic.